Today: 17 March 2026
Browse Category

Stock Market 17 December 2025

Amazon Stock (AMZN) News Today: OpenAI $10 Billion Talks Lift Shares as Analysts Refocus on AWS, Trainium, and 2026 Outlook

Amazon Stock (AMZN) News Today: OpenAI $10 Billion Talks Lift Shares as Analysts Refocus on AWS, Trainium, and 2026 Outlook

Amazon is in talks to invest about $10 billion in OpenAI, potentially valuing the ChatGPT-maker at over $500 billion, Reuters reported Wednesday. Amazon shares rose 1.4% in premarket trading to $225.68 after the news. OpenAI recently agreed to buy $38 billion in cloud services from Amazon and may use Amazon’s Trainium chips, according to Reuters.
Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP (NASDAQ: ATPC) surged to about $0.13 in after-hours trading on Dec. 17, 2025, after closing at $0.09, with volume topping 40 million shares. The move followed a company statement denying undisclosed developments and a new proxy filing proposing a reverse split and large authorized-share increase for a January 2026 vote.
European Stock Markets Today: STOXX 600 Near Record as Banks, Oil and Miners Rally on UK Inflation Surprise (Dec. 17, 2025)

European Stock Markets Today: STOXX 600 Near Record as Banks, Oil and Miners Rally on UK Inflation Surprise (Dec. 17, 2025)

The pan-European STOXX 600 rose 0.4% to 581.81 by mid-morning Wednesday, led by gains in banks, energy, and mining stocks. London’s FTSE 100 outperformed after UK inflation came in lower than expected, boosting hopes for a Bank of England rate cut. The FTSE 350 Banks index hit its highest since 2008. Energy shares tracked a jump in oil prices linked to Venezuela headlines.
17 December 2025
Australia Stock Market Today: ASX 200 slips to 8,585 as banks and energy weigh, while gold and lithium miners rally (Dec 17, 2025)

Australia Stock Market Today: ASX 200 slips to 8,585 as banks and energy weigh, while gold and lithium miners rally (Dec 17, 2025)

The S&P/ASX 200 closed down 13.7 points, or 0.16%, at 8,585.2 on Wednesday, marking its third straight loss as declines in banks and energy outweighed gains in gold and lithium stocks. Commonwealth Bank fell 0.8%, its worst day since August. Ten of 11 sectors ended lower. The Australian dollar slipped to around 0.6617 US.
17 December 2025
India Stock Market Today (Dec 17, 2025): Sensex slips 120, Nifty ends below 25,900 as FII selling and trade-deal uncertainty weigh; rupee rebounds on RBI support

India Stock Market Today (Dec 17, 2025): Sensex slips 120, Nifty ends below 25,900 as FII selling and trade-deal uncertainty weigh; rupee rebounds on RBI support

Mumbai’s Sensex fell 120.21 points to 84,559.65 and Nifty lost 41.55 to 25,818.55 on Wednesday, marking a third straight decline. Foreign investors sold $1.92 billion in December, while the rupee rebounded to 90.37 per dollar after RBI intervention. Market breadth showed 1,326 advances against 2,498 declines. Uncertainty over India–U.S. trade talks and global cues weighed on sentiment.
17 December 2025
Canada Stock Market Today: TSX Futures Edge Higher as Oil Jumps on Venezuela Blockade, Investors Eye Key Data and Rate Signals (Dec. 17, 2025)

Canada Stock Market Today: TSX Futures Edge Higher as Oil Jumps on Venezuela Blockade, Investors Eye Key Data and Rate Signals (Dec. 17, 2025)

S&P/TSX 60 December futures edged higher early Wednesday after oil prices rebounded sharply overnight on U.S. moves to block Venezuelan oil tankers. The main TSX index closed down 0.7% Tuesday, its third straight decline, led by a 3.7% drop in energy stocks. Brent crude rose to $60.33 a barrel, WTI to $56.69. The TSX remains up about 26% for 2025.
Transocean (RIG) Stock News and Forecast for Dec. 17, 2025: Analyst Moves, Backlog Updates, and 2026 Guidance

Transocean (RIG) Stock News and Forecast for Dec. 17, 2025: Analyst Moves, Backlog Updates, and 2026 Guidance

Transocean shares fell 5.88% to $3.84 on Dec. 16 after hitting a 52-week high of $4.45 earlier in December. Trading volume reached about 42.6 million shares. Morgan Stanley assumed coverage at Equal Weight with a $4.50 target, while Citi raised its target to $4.50 and JPMorgan maintained Underweight. Transocean recently secured a $130 million contract for the Deepwater Skyros in Australia.
17 December 2025
Asia Stock Markets Today: Nikkei, Hang Seng, Shanghai and Kospi Rise as Tech Rebounds; Australia, Malaysia Slip (Dec. 17, 2025)

Asia Stock Markets Today: Nikkei, Hang Seng, Shanghai and Kospi Rise as Tech Rebounds; Australia, Malaysia Slip (Dec. 17, 2025)

North Asian markets led gains in Asia on Wednesday, with Japan’s Nikkei up 0.26% and South Korea’s KOSPI rising 1.43% as chip and AI stocks rebounded. Mainland China’s CSI 300 jumped 1.83%. Australia’s ASX 200 slipped 0.2% amid banking-sector pressure. Investors positioned ahead of a Bank of Japan decision, while Thailand cut rates and Indonesia held steady.
17 December 2025
APA Corporation Stock (APA) News Today, Forecasts, and Analyst Outlook — What’s Driving APA Shares on Dec. 17, 2025

APA Corporation Stock (APA) News Today, Forecasts, and Analyst Outlook — What’s Driving APA Shares on Dec. 17, 2025

APA shares fell 5.18% to $23.96 Tuesday as oil prices hit multi-year lows on oversupply fears and talk of a Russia–Ukraine peace deal. Premarket Wednesday, APA traded higher near $24.43 after President Trump ordered a blockade of Venezuelan oil tankers, lifting crude by about 1.5%. Trading volume Tuesday reached 6.58 million shares.
Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune shares traded near $5.03 early Wednesday after closing at the same level Tuesday, with volatility elevated ahead of a key clinical update expected by year-end. The company’s valuation hinges on pemvidutide’s 48-week IMPACT Phase 2b readout for MASH, due in Q4 2025. Leadership changes and wide analyst price targets have added to market uncertainty. The stock jumped 12% intraday on Dec. 12 before retreating.
17 December 2025
Netflix Stock (NFLX) News Today, Dec. 17, 2025: Warner Bros. Deal Drama, Analyst Forecasts, and What Investors Are Watching

Netflix Stock (NFLX) News Today, Dec. 17, 2025: Warner Bros. Deal Drama, Analyst Forecasts, and What Investors Are Watching

Netflix shares traded near $94.60 in early premarket Wednesday after sliding 13% this month amid a bidding war for Warner Bros. Discovery. Netflix agreed Dec. 5 to acquire Warner Bros. and HBO for $72 billion in cash and stock. Paramount Skydance has since launched a hostile all-cash offer for WBD, intensifying deal uncertainty.
17 December 2025
Warner Bros. Discovery (WBD) Stock on Dec. 17, 2025: Board Seen Rejecting Paramount Bid as Netflix Deal Holds, Analysts Reprice the Upside

Warner Bros. Discovery (WBD) Stock on Dec. 17, 2025: Board Seen Rejecting Paramount Bid as Netflix Deal Holds, Analysts Reprice the Upside

Warner Bros. Discovery shares traded near $28.90 on Dec. 17 as its board prepared to recommend shareholders reject Paramount Skydance’s $30-per-share hostile bid and stick with a Netflix deal for non-cable assets. Jared Kushner’s Affinity Partners exited Paramount’s financing group, weakening its offer. The board’s response could come as soon as Wednesday. WBD shares slipped in premarket trading on the news.
Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever shares closed up 1.32% at 4,857.00p in London on December 17, 2025, following continued investor focus on its post-Magnum demerger strategy and M&A plans. The stock traded between 4,781.50p and 4,858.50p, with a market cap near £105.92 billion. No new regulatory filings were posted. Unilever moved above its 200-day moving average during Tuesday’s session.
17 December 2025
Rolls-Royce (RR.) share price rises as £200m buyback plan, US Army MV‑75 engine tests and UK SMR momentum dominate today’s headlines (17 Dec 2025)

Rolls-Royce (RR.) share price rises as £200m buyback plan, US Army MV‑75 engine tests and UK SMR momentum dominate today’s headlines (17 Dec 2025)

Rolls-Royce shares rose 2.3% in London on Wednesday to 1,123p after announcing a £200 million interim share buyback set to begin 2 January 2026. The company also reported new engine testing for the U.S. Army and fresh activity around UK small modular reactor sites. No new regulatory filings were posted today. Market cap stood near £93 billion.
Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025

Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025

Aditxt shares surged late December 17 after the company filed a definitive proxy for a January 30, 2026, special shareholder meeting. The agenda includes votes on potential share dilution, a reverse stock split, and a rebrand to “bitXbio, Inc.” Traders responded to the capital structure moves, not clinical news.

Stock Market Today

  • Agenus Q4 Earnings Exceed Estimates with $0.56 EPS and $34.2M Revenue
    March 16, 2026, 10:29 PM EDT. Agenus (AGEN) reported a quarterly earnings per share (EPS) of $0.56, significantly beating the Zacks Consensus Estimate loss of $1.27 and the previous year's $2.04 loss. This marked an earnings surprise of +144.27%. The biotechnology firm also posted revenues of $34.2 million, surpassing estimates by 17.54% and up from $26.84 million a year ago. Despite positive earnings and revenue surprises, Agenus stock has declined about 1.3% year-to-date, trailing the S&P 500's 3.1% drop. The company holds a Zacks Rank #3 (Hold), projecting in-line market performance ahead. Investors await management's commentary on the earnings call and future estimate revisions amid mixed consensus for upcoming quarters.
Go toTop